Our Voice | Our Community | Your Success
The Society for Clinical Research Sites (SCRS) was founded in 2012 in response to the growing need for a global organization representative of the needs of clinical research sites globally. SCRS currently represents over 9,500 research sites in 47 countries. SCRS’ mission is to unify the voice of the global clinical research site community for site sustainability. SCRS is an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise.
UPCOMING SITE SOLUTIONS SUMMITS
TESTIMONIALS
UPCOMING WEBINARS
Decentralized Technology: Preparing Today for the Study of Tomorrow
August 17, 2021 (12:00 pm ET)
LATEST NEWS
TWITTER @MYSCRS
SCRS developed the Diversity Site Assessment Tool (DSAT) to help sites quantify their competence to execute clinical trials with a diverse subject population.
To assess where your site stands, visit https://t.co/TQhCVFrSkD.
Join us for the latest SCRS Talks with Kay Scroggins, President and CEO of Clinical Trials of Texas, Inc. (CTT) and the SCRS 2021 Global Site Solutions Summit chair, as she shares what she is most excited about for this year’s Summit: https://t.co/HbOmrw2CEz
Society for Clinical Research Sites (@MySCRS) Diversity Site Assessment Tool (DSAT) is a tool designed to allow a self-assessment of your capacity for recruiting and meeting the needs of diverse patient populations in clinical trials. #ACORISummit #SU2C
https://t.co/oerLsUQnwU
Sites that consistently recruit diverse patient populations in clinical studies may have a competitive advantage against others. Understand how your site is performing in diverse recruitment and get resources to improve with the DSAT: https://t.co/4C0XlbZkWH
The Diversity Site Assessment Tool© (DSAT) is an intuitive self-assessment to quantify the capability of a clinical research site to execute clinical trials with a diverse population.
Assess where your site stands today: https://t.co/4C0XlbZkWH
Please join us in welcoming THREAD to the SCRS Global Impact Partner program!
Learn more: https://t.co/fxHGC6QBHT
The @US_FDA recently issued updated guidance to assist sponsors in assuring the safety of trial participants, maintaining compliance with GCP, and minimizing risks to trial integrity for the duration of the COVID-19 pandemic: https://t.co/lYZIShKGty
Headed to the @MySCRS Global Site Solutions Summit? From informative Master Workshops, Breakout Sessions, and Symposiums to the interactive EXPO Hall, this event will be action-packed! We broke down the must-attend activities. #SiteSolutionsSummit
https://t.co/nyyfSw8ZUA
The August issue of SCRS InFocus is out now! Get insights on diversity in research, regulatory trends and electronic data management, participation barriers for rare disease trials, TMF process improvements, and more: https://t.co/nUVWny8dQa
Is your site utilizing best practices for recruiting diverse patient populations? Use the SCRS Diversity Site Assessment Tool (DSAT) to understand how your site is doing and get resources to improve diverse population recruitment: https://t.co/4C0XlbZkWH